HomeEFTR • NASDAQ
add
eFFECTOR Therapeutics Inc
Previous close
$1.81
Day range
$1.81 - $1.96
Year range
$1.60 - $37.00
Market cap
6.97M USD
Avg Volume
624.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.52M | -8.15% |
Net income | -9.13M | 1.40% |
Net profit margin | — | — |
Earnings per share | -3.42 | 37.82% |
EBITDA | -8.57M | 1.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.37M | -30.18% |
Total assets | 20.54M | -29.35% |
Total liabilities | 26.34M | 4.60% |
Total equity | -5.80M | — |
Shares outstanding | 3.69M | — |
Price to book | -0.93 | — |
Return on assets | -105.61% | — |
Return on capital | -137.52% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.13M | 1.40% |
Cash from operations | -5.57M | 17.91% |
Cash from investing | 8.95M | 146.99% |
Cash from financing | 6.11M | 16,610.81% |
Net change in cash | 9.49M | 397.00% |
Free cash flow | -2.58M | 28.38% |
About
Founded
2012
Headquarters
Website
Employees
14